Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...61626364656667686970...
CompanyDrug NameStatusIndication Group
GlaxoSmithKline Advair Diskus 250/50 Approved in USARespiratory system
GlaxoSmithKline Advair 100 / 50 Approved in USARespiratory system
GlaxoSmithKline Advair Approved in USARespiratory system
Genvec AdPEDF in Phase ISensory organs
Biogen Idec ADENTRI accomplished Phase IICardiovascular system
Shire Adderall XR Approved in USANervous system
QLT Aczone Approved in USADermatologicals
Takeda Actos Approved in EUAlimentary tract & metabolism
Takeda Actos Submitted for approval in USA and EUAlimentary tract & metabolism
Takeda Actoplus Met Approved in USAAlimentary tract & metabolism
Cephalon Actiq Approved in USANervous system
InterMune Actimmune discontinuedAntineoplastic & immunomodulating agents
InterMune Actimmune discontinuedAntineoplastic & immunomodulating agents
Celgene ACTIMID in Phase IIAntineoplastic & immunomodulating agents
Coley Pharmaceutical Group Actilon in Phase IIAnti-infectives for systemic use
Roche Actemra Submitted for approval in Japan and USAMusculoskeletal system
Sanofi-aventis Acomplia Approved in USA and EUAlimentary tract & metabolism
Sanofi-aventis Acomplia discontinuedNervous system
Novartis Aclasta Approved in EU and USAMusculoskeletal system
Novartis Aclasta Approved in EUMusculoskeletal system
...61626364656667686970...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.